JP2012514020A5 - - Google Patents

Download PDF

Info

Publication number
JP2012514020A5
JP2012514020A5 JP2011544017A JP2011544017A JP2012514020A5 JP 2012514020 A5 JP2012514020 A5 JP 2012514020A5 JP 2011544017 A JP2011544017 A JP 2011544017A JP 2011544017 A JP2011544017 A JP 2011544017A JP 2012514020 A5 JP2012514020 A5 JP 2012514020A5
Authority
JP
Japan
Prior art keywords
phenyl
quinazolin
ylamino
chloro
hydroxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2011544017A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012514020A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2009/067494 external-priority patent/WO2010076238A1/en
Publication of JP2012514020A publication Critical patent/JP2012514020A/ja
Publication of JP2012514020A5 publication Critical patent/JP2012514020A5/ja
Pending legal-status Critical Current

Links

JP2011544017A 2008-12-29 2009-12-18 置換キナゾリン化合物 Pending JP2012514020A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP08360043 2008-12-29
EP08360043.7 2008-12-29
PCT/EP2009/067494 WO2010076238A1 (en) 2008-12-29 2009-12-18 Substituted quinazoline compounds

Publications (2)

Publication Number Publication Date
JP2012514020A JP2012514020A (ja) 2012-06-21
JP2012514020A5 true JP2012514020A5 (https=) 2013-03-28

Family

ID=41735344

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011544017A Pending JP2012514020A (ja) 2008-12-29 2009-12-18 置換キナゾリン化合物

Country Status (23)

Country Link
US (1) US8389530B2 (https=)
EP (1) EP2381943A1 (https=)
JP (1) JP2012514020A (https=)
KR (1) KR20110120878A (https=)
CN (1) CN102333533A (https=)
AU (1) AU2009334869A1 (https=)
BR (1) BRPI0924067A2 (https=)
CA (1) CA2748319A1 (https=)
CO (1) CO6390105A2 (https=)
CR (1) CR20110368A (https=)
DO (1) DOP2011000209A (https=)
EA (1) EA019110B1 (https=)
EC (1) ECSP11011204A (https=)
IL (1) IL213742A0 (https=)
MA (1) MA32968B1 (https=)
MX (1) MX2011007064A (https=)
NI (1) NI201100134A (https=)
NZ (1) NZ593949A (https=)
PE (1) PE20120424A1 (https=)
SG (1) SG172415A1 (https=)
TN (1) TN2011000319A1 (https=)
WO (1) WO2010076238A1 (https=)
ZA (1) ZA201104777B (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR081960A1 (es) 2010-06-22 2012-10-31 Fovea Pharmaceuticals Sa Compuestos heterociclicos, su preparacion y su aplicacion terapeutica
SG11201500125QA (en) 2012-07-11 2015-02-27 Blueprint Medicines Corp Inhibitors of the fibroblast growth factor receptor
RS63405B1 (sr) 2013-10-25 2022-08-31 Blueprint Medicines Corp Inhibitori receptora faktora rasta fibroblasta
US9695165B2 (en) 2014-01-15 2017-07-04 Blueprint Medicines Corporation Inhibitors of the fibroblast growth factor receptor
KR101715448B1 (ko) * 2014-07-16 2017-03-20 주식회사 큐리언트 염증성 질환 치료용 화합물
SG11201705192PA (en) 2014-12-24 2017-07-28 Gilead Sciences Inc Fused pyrimidine compounds for the treatment of hiv
TWI699355B (zh) 2014-12-24 2020-07-21 美商基利科學股份有限公司 喹唑啉化合物
BR112017013440A2 (pt) 2014-12-24 2018-01-09 Gilead Sciences, Inc. compostos de isoquinolina para o tratamento de hiv
CN112239459B (zh) * 2019-07-19 2021-11-26 中国科学院上海药物研究所 稠环嘧啶氨基化合物、其制备方法、药物组合物及应用
CN115916759B (zh) * 2020-06-19 2025-07-15 泰州红云制药有限公司 取代喹唑啉类化合物、其制备方法、药物组合及应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1235815A1 (en) * 1999-11-22 2002-09-04 Warner-Lambert Company Quinazolines and their use for inhibiting cyclin-dependent kinase enzymes
MXPA05007503A (es) 2003-01-17 2005-09-21 Warner Lambert Co Heterociclicos 2-aminopiridina sustituidos como inhibidores de proliferacion celular.
US7691866B2 (en) 2003-10-16 2010-04-06 Novartis Vaccines And Diagnostics, Inc. 2,6-disubstituted quinazolines, quinoxalines, quinolines and isoquinolines and methods of their use as inhibitors of Raf kinase
EP2543376A1 (en) 2004-04-08 2013-01-09 Targegen, Inc. Benzotriazine inhibitors of kinases
US7652051B2 (en) 2004-08-25 2010-01-26 Targegen, Inc. Heterocyclic compounds and methods of use
US20070054916A1 (en) 2004-10-01 2007-03-08 Amgen Inc. Aryl nitrogen-containing bicyclic compounds and methods of use
JP2008533166A (ja) 2005-03-16 2008-08-21 ターゲジェン インコーポレーティッド ピリミジン化合物および使用法
US7906522B2 (en) * 2005-04-28 2011-03-15 Kyowa Hakko Kirin Co., Ltd 2-aminoquinazoline derivatives
AU2006254825A1 (en) 2005-06-08 2006-12-14 Targegen, Inc. Methods and compositions for the treatment of ocular disorders
AR060358A1 (es) * 2006-04-06 2008-06-11 Novartis Vaccines & Diagnostic Quinazolinas para la inhibicion de pdk 1
JP2010514693A (ja) * 2006-12-22 2010-05-06 ノバルティス アーゲー Pdk1阻害のためのキナゾリン

Similar Documents

Publication Publication Date Title
JP2012514020A5 (https=)
JP2009535362A5 (https=)
CA2748319A1 (en) Substituted quinazoline compounds of general formula (i) and uses thereof for treating disorders relating to tyrosine kinase dysregulation
JP2009534398A5 (https=)
JP2009534471A5 (https=)
ES2552977T3 (es) Amino-quinolinas como inhibidores de quinasa
JP2012510502A5 (https=)
TW434227B (en) Novel N-benzylindole and benzopyrazole derivatives with anti-asthmatic, anti-allergic, anti-inflammatory and immune modulating effect
ME01462B (me) Vinilindazolilna jedinjenja"
ES2324710T3 (es) Indolinonas sustituidas con heterociclos y su uso como inhibidores de receptores de tirosina quinasa.
JP2008513500A5 (https=)
CA3172387A1 (en) Indazole based compounds and associated methods of use
JP2008536825A5 (https=)
JP2009535356A5 (https=)
RU2014109853A (ru) Соединения для связывания со специфическим для тромбоцитов гликопротеином iib/iiia и их применение для визуализации тромбов
JP2006500348A5 (https=)
JP2007524696A5 (https=)
JP2005509624A5 (https=)
JP2010521451A5 (https=)
HRP20120895T1 (hr) Imidazokinolini sa imuno-modulacijskim svojstvima
ATE509935T1 (de) Mischungen aus mono-carboxylfunktionalisierten dialkylphosphinsäuren, ein verfahren zu ihrer herstellung und ihre verwendung
JP2005539000A (ja) Alk5阻害剤としての2−フェニルピリジン−4−イル誘導体
JP2005529954A5 (https=)
CA2628233A1 (en) 5-lipoxygenase-activating protein (flap) inhibitors
RU2013153540A (ru) Аминопиридинсодержащие ингибиторы тирозинкиназы селезенки (syk)